全文获取类型
收费全文 | 17810篇 |
免费 | 1701篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 176篇 |
儿科学 | 614篇 |
妇产科学 | 412篇 |
基础医学 | 2243篇 |
口腔科学 | 435篇 |
临床医学 | 2017篇 |
内科学 | 3432篇 |
皮肤病学 | 181篇 |
神经病学 | 1762篇 |
特种医学 | 489篇 |
外科学 | 2521篇 |
综合类 | 522篇 |
一般理论 | 41篇 |
预防医学 | 1870篇 |
眼科学 | 310篇 |
药学 | 1420篇 |
中国医学 | 7篇 |
肿瘤学 | 1083篇 |
出版年
2023年 | 114篇 |
2022年 | 185篇 |
2021年 | 334篇 |
2020年 | 247篇 |
2019年 | 357篇 |
2018年 | 409篇 |
2017年 | 300篇 |
2016年 | 308篇 |
2015年 | 334篇 |
2014年 | 542篇 |
2013年 | 770篇 |
2012年 | 971篇 |
2011年 | 986篇 |
2010年 | 492篇 |
2009年 | 486篇 |
2008年 | 809篇 |
2007年 | 857篇 |
2006年 | 795篇 |
2005年 | 821篇 |
2004年 | 684篇 |
2003年 | 685篇 |
2002年 | 606篇 |
2001年 | 518篇 |
2000年 | 457篇 |
1999年 | 449篇 |
1998年 | 206篇 |
1997年 | 138篇 |
1996年 | 163篇 |
1995年 | 163篇 |
1994年 | 153篇 |
1993年 | 142篇 |
1992年 | 357篇 |
1991年 | 331篇 |
1990年 | 314篇 |
1989年 | 316篇 |
1988年 | 296篇 |
1987年 | 302篇 |
1986年 | 287篇 |
1985年 | 265篇 |
1984年 | 210篇 |
1983年 | 176篇 |
1982年 | 158篇 |
1981年 | 129篇 |
1979年 | 152篇 |
1978年 | 116篇 |
1976年 | 127篇 |
1975年 | 107篇 |
1974年 | 125篇 |
1973年 | 139篇 |
1972年 | 128篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Geneticists have, for years, understood the nature of genome‐wide association studies using common genomic variants. Recently, however, focus has shifted to the analysis of rare variants. This presents potential problems for researchers, as rare variants do not always behave in the same way common variants do, sometimes rendering decades of solid intuition moot. In this paper, we present examples of the differences between common and rare variants. We show why one must be significantly more careful about the origin of rare variants, and how failing to do so can lead to highly inflated type I error. We then explain how to best avoid such concerns with careful understanding and study design. Additionally, we demonstrate that a seemingly low error rate in next‐generation sequencing can dramatically impact the false‐positive rate for rare variants. This is due to the fact that rare variants are, by definition, seen infrequently, making it hard to distinguish between errors and real variants. Compounding this problem is the fact that the proportion of errors is likely to get worse, not better, with increasing sample size. One cannot simply scale their way up in order to solve this problem. Understanding these potential pitfalls is a key step in successfully identifying true associations between rare variants and diseases. 相似文献
2.
3.
C. Lindsay DeVane 《Pharmacotherapy》2016,36(9):953-954
4.
5.
6.
Adrenal disorders in pregnancy. 总被引:1,自引:0,他引:1
7.
8.
9.
A new range of stand magnifiers has been released by the COIL company in the United Kingdom. Examination of these magnifiers reveals that they fail to deliver the rated magnifications labelled prominently on the appliances, as a result of the manufacturer's conformance with the requirements of the German DIN standard and the use of back vertex power (F'v) rather than equivalent dioptric power (Fm) of the magnifier. In this study we provide information on the optometric parameters of these new stand magnifiers that will assist the more accurate specification of improvements in vision expected from their use. 相似文献
10.
Sixty-three mallards were fed one of ten poly(methyl methacrylate) based synthetic grit formulations containing varying concentrations of a proposed wildlife contraceptive (nicarbazin), plasticizer (acetyl tributylcitrate) and/or cross-linking agent (1,4-butanediol diacrylate). Release characteristics of the contraceptive agent were monitored for the purpose of developing a contraceptive formulation for control of pest waterfowl in urban settings. The addition of plasticizer increased the erosion rate (t(1/2)=0.97-2.85 days), cross-linking the polymer matrix slightly decreased the erosion rate (t(1/2)=4.45-5.05 days) and increasing the concentration of the contraceptive agent increased the erosion rate (t(1/2)=3.3 and 9.9 days at 60% and 7.5% active ingredient, respectively). The larger and smaller grit pieces had longer half lives at 11.0 and 11.6 days, respectively while the mid sized grit had a half life of 4.95 days. Control grit had a half life of 12.7 days based on weight loss. Analysis of blood and feces for monitoring release from the grit and approximate indirect plasma levels of the active ingredient proved feasible. 相似文献